Purinergic Signalling

Scope & Guideline

Fostering Innovation in Molecular and Cellular Biology

Introduction

Welcome to the Purinergic Signalling information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Purinergic Signalling, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1573-9538
PublisherSPRINGER
Support Open AccessNo
CountryNetherlands
TypeJournal
Convergefrom 2004 to 2024
AbbreviationPURINERG SIGNAL / Purinergic Signal.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressVAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS

Aims and Scopes

The journal 'Purinergic Signalling' focuses on the diverse roles of purines and purinergic receptors in various biological processes and diseases. It aims to advance understanding of purinergic signaling and its implications for therapeutic interventions.
  1. Purinergic Signaling Mechanisms:
    Exploration of the biochemical pathways and molecular mechanisms involving purines, including ATP and adenosine, in cellular communication and signaling.
  2. Role in Disease Pathology:
    Investigation into how purinergic signaling contributes to the pathophysiology of various diseases, including cancer, neurodegenerative diseases, cardiovascular conditions, and inflammation.
  3. Therapeutic Applications:
    Research on potential therapeutic approaches targeting purinergic receptors and signaling pathways for the treatment of diseases such as cancer, pain, and inflammatory disorders.
  4. Neuropharmacology:
    Studies on the effects of purines on the nervous system, including their roles in neuroprotection, synaptic transmission, and neuroinflammation.
  5. Cellular and Molecular Biology:
    Research focusing on the cellular mechanisms of purinergic signaling, including receptor expression, signal transduction, and interactions with other signaling pathways.
The journal is increasingly focusing on emerging themes and trends in purinergic signaling research, reflecting the evolving landscape of this field.
  1. Purinergic Signaling in Cancer:
    A growing body of research is investigating the roles of purinergic receptors, especially P2X and P2Y families, in tumor progression, metastasis, and the immune response in cancer.
  2. Neuroinflammation and Neurodegeneration:
    There is an emerging focus on the role of purinergic signaling in neuroinflammatory processes and neurodegenerative diseases, highlighting its potential as a therapeutic target.
  3. Electroacupuncture and Pain Management:
    Recent studies are increasingly exploring the role of purinergic signaling in the mechanisms of acupuncture analgesia, positioning it as a promising area for pain management research.
  4. Microglial Function and Purinergic Modulation:
    Research on microglial cells and their purinergic signaling pathways is trending, emphasizing their role in neuroinflammation and brain health.
  5. Machine Learning in Purinergic Research:
    The application of machine learning techniques to identify novel ligands and predict receptor interactions is an emerging trend, indicating a shift towards more computational approaches in purinergic research.

Declining or Waning

While the journal continues to publish a wide range of topics, certain themes have shown a decline in frequency or prominence over the recent years.
  1. Historical Perspectives on Purinergic Research:
    Papers focusing on historical reviews or tributes to foundational figures in purinergic research have decreased, suggesting a shift towards more contemporary applications and findings.
  2. Basic Science without Clinical Relevance:
    There is a noticeable reduction in publications that are strictly focused on basic science without clear clinical implications, as the journal appears to be prioritizing studies with direct therapeutic relevance.
  3. Purinergic Mechanisms in Non-Mammalian Models:
    Research on purinergic signaling in non-mammalian systems has become less frequent, indicating a possible shift towards mammalian models that are more relevant to human health and disease.

Similar Journals

ACTA BIOCHIMICA ET BIOPHYSICA SINICA

Exploring the Molecular Foundations of Biological Phenomena.
Publisher: SCIENCE PRESSISSN: 1672-9145Frequency: 12 issues/year

ACTA BIOCHIMICA ET BIOPHYSICA SINICA, an esteemed journal published by SCIENCE PRESS, is a leading platform in the fields of biochemistry, biophysics, and molecular biology. Based in the United Kingdom, this journal has consistently ranked in the Q2 category for Biochemistry, Biophysics, and Medicine (miscellaneous) in 2023, showcasing its commitment to high-quality research and innovation in life sciences. With a convergence period extending from 1996 to 2024, it features critical insights into biochemical and biophysical processes that underlie biological phenomena. Researchers and professionals seeking to stay at the forefront of discoveries will find its articles to be both informative and transformative. Although not an open-access journal, ACTA BIOCHIMICA ET BIOPHYSICA SINICA aims to advance knowledge and foster collaboration among scientists worldwide, emphasizing its role in the dynamic landscape of biomedical research.

Animal Cells and Systems

Connecting Cellular Biology with Organismal Function
Publisher: TAYLOR & FRANCIS LTDISSN: 1976-8354Frequency: 6 issues/year

Animal Cells and Systems, published by TAYLOR & FRANCIS LTD, is a prominent open-access journal that has been disseminating high-quality research since 2017. With an ISSN of 1976-8354 and an E-ISSN of 2151-2485, this journal is dedicated to advancing the understanding of animal cellular biology and the intricate systems that govern organismal functions. Recognized for its rigorous peer-review process, it holds an esteemed position in the academic community, boasting a Q1 ranking in Animal Science and Zoology and a Q2 ranking in Biochemistry, Genetics and Molecular Biology for 2023. The journal is indexed in Scopus, ranked #79/490 in Animal Science and Zoology and #85/221 in General Biochemistry, Genetics, and Molecular Biology, affirming its impact and relevance in these fields. With a commitment to providing researchers, professionals, and students with vital insights and cutting-edge research, Animal Cells and Systems is an essential resource for those looking to explore the complex landscapes of animal biology.

CELLULAR AND MOLECULAR BIOLOGY

Connecting Researchers in Cellular Dynamics
Publisher: C M B ASSOCISSN: 0145-5680Frequency: 8 issues/year

Cellular and Molecular Biology is a prominent academic journal published by C M B ASSOC, specializing in the dynamic fields of cellular and molecular biology. Established in 1977, this journal has consistently aimed to disseminate groundbreaking research that contributes to our understanding of biochemical processes, cell dynamics, and molecular mechanisms governing life. With its ISSN 0145-5680 and E-ISSN 1165-158X, the journal plays a vital role in the exchange of innovative ideas, evidenced by its coverage of research from 1977 to 2024. Although currently categorized in the Q4 quartile for major disciplines such as Biochemistry and Cell Biology, it is dedicated to fostering the development of the field by welcoming submissions that challenge the conventional understanding and lead to novel insights. Researchers and academics looking to contribute to or stay updated in the rapidly evolving landscape of molecular biology will find this journal a valuable resource for connecting with a global community of scientists.

Genes & Diseases

Innovating solutions through genetic research and discovery.
Publisher: KEAI PUBLISHING LTDISSN: 2352-4820Frequency: 6 issues/year

Genes & Diseases, published by KEAI PUBLISHING LTD, is a premier open-access journal dedicated to advancing the fields of genetics, biochemistry, and molecular biology. Established in 2014 and headquartered in Beijing, China, this journal has quickly risen to prominence, securing a place in the prestigious Q1 quartile in Biochemistry and Genetics (clinical), as well as Q2 in Cell Biology and Q1 in Molecular Biology as of 2023. With a commitment to disseminating cutting-edge research, Genes & Diseases serves as a critical platform for researchers, professionals, and students alike, ensuring that high-quality scientific work is openly accessible to the global community. The journal's exceptional impact is underscored by its selective Scopus rankings, which reflect its influence and relevance in key scientific domains, making it an essential resource for those exploring the intersections of genetics and disease pathology.

FEBS LETTERS

Elevating Scientific Discourse in Biological Fields
Publisher: WILEYISSN: 0014-5793Frequency: 24 issues/year

FEBS LETTERS, published by Wiley, is a prestigious journal that has firmly established its place in the fields of biochemistry, biophysics, genetics, molecular biology, cell biology, and structural biology. With an esteemed history dating back to 1968, this journal continues to be a vital resource for researchers and professionals involved in the biological sciences. It boasts impressive quartile rankings, including Q1 statuses in several categories such as Biochemistry and Genetics, reflecting its high impact factor and significant contribution to scientific discourse. FEBS LETTERS provides a platform for innovative findings and critical reviews, fostering the exchange of knowledge and ideas within the scientific community. Although it operates under a subscription model, the journal ensures broad dissemination of groundbreaking research through its rigorous peer-review process. The vibrant discussions encouraged by articles published in FEBS LETTERS aim to inspire current and future generations of scientists to push the boundaries of biological understanding, making it an indispensable resource for anyone dedicated to advancing their knowledge in these dynamic fields.

MOLECULAR AND CELLULAR BIOLOGY

Unveiling Cellular Mechanisms for a Brighter Tomorrow
Publisher: TAYLOR & FRANCIS INCISSN: 0270-7306Frequency: 24 issues/year

MOLECULAR AND CELLULAR BIOLOGY, published by TAYLOR & FRANCIS INC, stands as a preeminent platform for researchers, professionals, and students engaged in the dynamic field of molecular and cellular biology. Established in 1981 and ongoing into 2024, the journal features cutting-edge research that spans across vital sub-disciplines, garnering a strong impact in its contributions to the scientific community. With an impressive Q2 ranking in Cell Biology and Q1 ranking in Molecular Biology for 2023, it consistently publishes high-quality articles that reflect the latest advancements and discoveries within the field. The journal is particularly well-regarded for its rigorous peer-review process and commitment to scientific excellence, making it an invaluable resource for those seeking to deepen their understanding of molecular mechanisms and cellular processes. Although not open access, the journal offers diverse access options for researchers to reach the latest findings. By maintaining a strong focus on biochemistry, genetics, and molecular biology, MOLECULAR AND CELLULAR BIOLOGY remains essential reading for anyone looking to contribute to or stay informed about significant developments within this pivotal area of study.

FASEB BioAdvances

Driving Innovation in Molecular Biology Research
Publisher: WILEYISSN: Frequency: 12 issues/year

FASEB BioAdvances, published by WILEY, is an esteemed open-access journal dedicated to advancing the fields of biochemistry, molecular biology, and physiology. Since its inception in 2019, the journal has rapidly established a significant presence within the academic community, boasting an impressive impact factor reflective of its Q2 and Q3 standings across various categories, including Biochemistry, Genetics and Molecular Biology, Cancer Research, Molecular Medicine, and Physiology. The journal aims to disseminate high-quality research and innovative findings to enhance the understanding of biological processes, making it a vital resource for researchers, professionals, and students alike. With its commitment to open access, FASEB BioAdvances ensures that groundbreaking research is available to a global audience, facilitating collaboration and exploration in these rapidly evolving scientific domains.

Cell Communication and Signaling

Exploring the Nuances of Molecular Signaling
Publisher: BMCISSN: Frequency: 1 issue/year

Cell Communication and Signaling is a premier peer-reviewed journal published by BMC that has made significant contributions to the fields of biochemistry, cell biology, and molecular biology since its establishment in 2003. As an open access journal, it offers unrestricted access to high-quality research, fostering collaboration and innovation among scientists around the globe. The journal is distinguished by its Q1 ranking in all three relevant categories for 2023, underscoring its critical role in advancing the understanding of cellular communication mechanisms and signaling pathways. Positioned within the United Kingdom, Cell Communication and Signaling has been an invaluable resource for researchers, professionals, and students alike, ensuring that the latest findings are accessible to a diverse range of audiences. With an impressive Scopus ranking—placing it in the top percentiles within its subject areas—this journal continues to set the standard for excellence in the pursuit of understanding complex cellular interactions.

BIOSCIENCE REPORTS

Connecting Researchers with Groundbreaking Findings
Publisher: PORTLAND PRESS LTDISSN: 0144-8463Frequency: 6 issues/year

BIOSCIENCE REPORTS, published by Portland Press Ltd, is a prestigious journal dedicated to advancing the fields of biochemistry, biophysics, cell biology, and molecular biology. Founded in 1981, the journal has established itself as a vital resource for researchers and professionals, boasting a significant impact factor and high rankings within its categories, including Q2 in Biochemistry and Q1 in Biophysics as of 2023. The journal’s commitment to high-quality, peer-reviewed research ensures that it remains an influential platform for the dissemination of cutting-edge scientific findings. While it operates under a traditional subscription model, it offers various access options to accommodate the needs of the scientific community. With ongoing publication through 2024, BIOSCIENCE REPORTS continues to play a crucial role in shaping discussions in the life sciences and fostering innovative research in biology.

EUROPEAN JOURNAL OF HISTOCHEMISTRY

Innovating methodologies for a deeper understanding of life sciences.
Publisher: PAGEPRESS PUBLISSN: 1121-760XFrequency: 4 issues/year

European Journal of Histochemistry (ISSN: 1121-760X; E-ISSN: 2038-8306) is a distinguished peer-reviewed scholarly journal published by PAGEPRESS PUBL based in Italy. Since its inception in 1992 and with a commitment to Open Access since 2010, the journal has played a pivotal role in disseminating high-quality research in the fields of Histology, Biophysics, and Cell Biology. As of 2023, the journal holds a commendable position within the academic community, achieving Q2 rankings in Biophysics, Histology, and Medicine (miscellaneous), further highlighting its relevance and impact in these critical areas of research. Despite its HIndex not being specified, its Scopus rankings demonstrate the journal's competitive edge, particularly in Histology (Rank #33/62) and Biophysics (Rank #84/152). The journal aims to provide a platform for researchers to share innovative findings and contribute to the enrichment of knowledge in histochemical methodologies and their application to biomedical sciences. Its Open Access model ensures the broadest possible dissemination of research, making it an essential resource for researchers, professionals, and students alike who are engaged in the life sciences. For more information, visit the journal's webpage hosted by PAGEPRESS PUBL.